Abeona Therapeutics (ABEO) Interest Income - Total (2021 - 2026)
Abeona Therapeutics (ABEO) recorded quarterly Interest Income - Total of $1.4 million in Q1 2026, down 12.48% quarter-over-quarter from $1.5 million in Q4 2025, and up 3.36% on a YoY basis from $1.3 million in Q1 2025.
Abeona Therapeutics (ABEO) Interest Income - Total (2021 - 2026) Analysis & Trends
Abeona Therapeutics' Interest Income - Total history runs 6 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Interest Income - Total rose 3.36% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $5.6 million (up 18.82% YoY), while the FY2025 annual figure was $5.6 million, up 30.85% from the prior year.
- Interest Income - Total was $1.4 million for Q1 2026 at Abeona Therapeutics, down from $1.5 million in the prior quarter.
- In the past five years, Interest Income - Total ranged from a high of $1.7 million in Q3 2025 to a low of $7000.0 in Q1 2022.
- Historically, Interest Income - Total has averaged $806529.4 across 5 years, with a median of $843000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Interest Income - Total soared 6460.0% in 2022, then fell 13.77% in 2025.
- A 5-year view of Interest Income - Total shows it stood at $328000.0 in 2022, then surged by 126.52% to $743000.0 in 2023, then surged by 37.69% to $1.0 million in 2024, then surged by 51.22% to $1.5 million in 2025, then decreased by 12.48% to $1.4 million in 2026.
- The last three Interest Income - Total figures came in at $1.4 million (Q1 2026), $1.5 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Total (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn | 1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.35 Mn |
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 843,000.00 |
| Mar 31, 2024 | 843,000.00 |
| Dec 31, 2023 | 743,000.00 |
| Dec 31, 2023 | 743,000.00 |